ausbiz: Racing ahead – successful trial & board revamp at Race Oncology
CEO and MD Dr Daniel Tillett joined ausbiz post the release of September Quarterly Activity Report, reaffirming the company’s strong funding position, clinical pipeline, and noting changes in the Board and Management team.
Watch the full interview via this link.